loder

Global HIV Vaccine Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report

Global HIV Vaccine Market - Vaccine type: preventive vaccines, therapeutic vaccines; Technology: DNA/viral‑vector vaccines, protein subunit vaccines, others; End user: hospitals, research institutes, public health programs.​
Report Code
CMI_085
Published
May 2, 2024
Last Updated
April 17, 2026
Coverage
Healthcare • Pharma
Analyst-led, consultative delivery
Enterprise-ready licensing options
Fast turnarounds for custom cuts

Market Snapshot

High-signal KPIs designed for executive scanning.
Indicative snapshot. Request sample for full model outputs.
Market Size (latest)
vs. prior year
CAGR
Forecast window:
Forecast Period
2024–2031
Base years: 2019–2023
Coverage Depth
Segments • Regions • Players

Insights

Consultative narrative + actionable decision support.
Preview available upon request.
Get sample pages, TOC and analyst summary.
Unlock the executive summary.
Request the sample to review key questions answered.
See what’s included.
Request sample for scope, definitions and segmentation.

Key Players

  • Company 1
  • Company 2
  • Company 3
  • Company 4
  • Company 13
Competitive Dashboard Preview
Shortlist strategic accounts and benchmark positioning.
Loading…
Request Competitive Cut

Segmentation Explorer

Interactively explore markets by segment and geography.
Refine View
Opportunity Index
Directional signals for prioritization and scenario framing.
Interactive
Need a board-ready slide? .
Modeling inputs: analyst assumptions, secondary sources, triangulated validations.

Table Of Contents

Expandable preview of coverage and chapter structure.
Global HIV Vaccine Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report Report

Global HIV Vaccine Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report Report


  1. 1. Global HIV Vaccine Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report Research Report
    1. 1.1 Study Objectives
    2. 1.2 Global HIV Vaccine Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report - Overview
    3. 1.3 Reason to Read This Report
    4. 1.4 Methodology and Forecast Analysis
  2. 2. Global HIV Vaccine Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report Research Report - Preface
    1. 2.1 Global HIV Vaccine Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report Research Report – Detailed Scope and Definitions
      1. 2.1.1 Vaccine type
      2. 2.1.2 Technology
      3. 2.1.3 End user
      4. 2.1.4 By Region
  3. 3. Global HIV Vaccine Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report Dynamics
    1. 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
    2. 3.2. Restraints – Vaccine type, Technology, End user, By Country
    3. 3.3. Opportunities – Vaccine type, Technology, End user, By Country
    4. 3.4. Trends – Vaccine type, Technology, End user, By Country
    5. 3.5. PEST Analysis
    6. 3.6. Porters Five Rule Analysis
    7. 3.7. Company’s Share Analysis (CSA) by Region or By Country
    8. 3.8. Global HIV Vaccine Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report Research Report – DROTs Impact Analysis
      4. Global HIV Vaccine Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report Research Report, Historic Data 2019 - 2023 and Forecast Analysis Data 2024 - 2031
    1. 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    2. 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
    3. 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
    4. 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    5. Global HIV Vaccine Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report, Vaccine type, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
      5.1 preventive vaccines
    1. 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    2. 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    3. 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    4. 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    5. 5.2 therapeutic vaccines
    6. 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    7. 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    8. 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    9. 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    6. Global HIV Vaccine Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report, Technology, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
      6.1 DNA/viral‑vector vaccines
    1. 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    2. 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    3. 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    4. 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    5. 6.2 protein subunit vaccines
    6. 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    7. 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    8. 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    9. 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    10. 6.3 others
    11. 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    12. 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    13. 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    14. 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    7. Global HIV Vaccine Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report, End user, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
      7.1 hospitals
    1. 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    2. 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    3. 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    4. 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    5. 7.2 research institutes
    6. 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    7. 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    8. 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    9. 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    10. 7.3 public health programs.​
    11. 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
    12. 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
    13. 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
    14. 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
    8. Global HIV Vaccine Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report Forecast, By Region, 2019 - 2023 and 2024 - 2031 (Market Value, In USD Mn)
      8.1 North America
      1. 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      8.2 Europe
      1. 8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      8.3 Asia-Pacific
      1. 8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      8.4 Latin America
      1. 8.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      8.5 Middle East & Africa
      1. 8.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
      2. 8.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
      3. 8.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
      4. 8.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
      8.6 Global HIV Vaccine Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report - Opportunity Analysis Index, Vaccine type, Technology, End user, and Region, 2024 - 2031
    9. North America Global HIV Vaccine Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
      9.1 Vaccine type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.1.1 preventive vaccines
      2. 9.1.2 therapeutic vaccines
      9.2 Technology Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.2.1 DNA/viral‑vector vaccines
      2. 9.2.2 protein subunit vaccines
      3. 9.2.3 others
      9.3 End user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.3.1 hospitals
      2. 9.3.2 research institutes
      3. 9.3.3 public health programs.​
      9.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 9.4.1 United States
      2. 9.4.2 Canada
    1. 9.5 North America Global HIV Vaccine Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report – Opportunity Analysis Index, Vaccine type, Technology, End user, and Country, 2024 - 2031
    2. 9.6 Regional Trends Analysis
    3. 9.7 North America Global HIV Vaccine Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report Research Report - Company Profiles
      1. 9.7.1 Company 1 (United States)
      2. 9.7.2 Company 2 (Canada)
      3. 9.7.3 Company 3 (Canada)
    10. Europe Global HIV Vaccine Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
      10.1 Vaccine type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.1.1 preventive vaccines
      2. 10.1.2 therapeutic vaccines
      10.2 Technology Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.2.1 DNA/viral‑vector vaccines
      2. 10.2.2 protein subunit vaccines
      3. 10.2.3 others
      10.3 End user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.3.1 hospitals
      2. 10.3.2 research institutes
      3. 10.3.3 public health programs.​
      10.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 10.4.1 Germany
      2. 10.4.2 United Kingdom
      3. 10.4.3 France
      4. 10.4.4 Spain
      5. 10.4.5 Italy
      6. 10.4.6 Russia
      7. 10.4.7 Netherlands
      8. 10.4.8 Poland
      9. 10.4.9 Rest of Europe
    1. 10.5 Europe Global HIV Vaccine Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report – Opportunity Analysis Index, Vaccine type, Technology, End user, and Country, 2024 - 2031
    2. 10.6 Regional Trends Analysis
    3. 10.7 Europe Global HIV Vaccine Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report Research Report - Company Profiles
      1. 10.7.1 Company 1 (Germany)
      2. 10.7.2 Company 2 (United Kingdom)
      3. 10.7.3 Company 3 (United Kingdom)
    11. Asia-Pacific Global HIV Vaccine Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
      11.1 Vaccine type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.1.1 preventive vaccines
      2. 11.1.2 therapeutic vaccines
      11.2 Technology Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.2.1 DNA/viral‑vector vaccines
      2. 11.2.2 protein subunit vaccines
      3. 11.2.3 others
      11.3 End user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.3.1 hospitals
      2. 11.3.2 research institutes
      3. 11.3.3 public health programs.​
      11.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 11.4.1 China
      2. 11.4.2 Japan
      3. 11.4.3 India
      4. 11.4.4 South Korea
      5. 11.4.5 Australia & NZ
      6. 11.4.6 ASEAN
      7. 11.4.7 Rest of Asia-Pacific
    1. 11.5 Asia-Pacific Global HIV Vaccine Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report – Opportunity Analysis Index, Vaccine type, Technology, End user, and Country, 2024 - 2031
    2. 11.6 Regional Trends Analysis
    3. 11.7 Asia-Pacific Global HIV Vaccine Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report Research Report - Company Profiles
      1. 11.7.1 Company 1 (China)
      2. 11.7.2 Company 2 (Japan)
      3. 11.7.3 Company 3 (Japan)
    12. Latin America Global HIV Vaccine Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
      12.1 Vaccine type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.1.1 preventive vaccines
      2. 12.1.2 therapeutic vaccines
      12.2 Technology Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.2.1 DNA/viral‑vector vaccines
      2. 12.2.2 protein subunit vaccines
      3. 12.2.3 others
      12.3 End user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.3.1 hospitals
      2. 12.3.2 research institutes
      3. 12.3.3 public health programs.​
      12.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 12.4.1 Brazil
      2. 12.4.2 Mexico
      3. 12.4.3 Argentina
      4. 12.4.4 Peru
      5. 12.4.5 Colombia
      6. 12.4.6 Rest of Latin America
    1. 12.5 Latin America Global HIV Vaccine Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report – Opportunity Analysis Index, Vaccine type, Technology, End user, and Country, 2024 - 2031
    2. 12.6 Regional Trends Analysis
    3. 12.7 Latin America Global HIV Vaccine Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report Research Report - Company Profiles
      1. 12.7.1 Company 1 (Brazil)
      2. 12.7.2 Company 2 (Mexico)
      3. 12.7.3 Company 3 (Mexico)
    13. Middle East & Africa Global HIV Vaccine Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report Analysis, 2019 - 2023 and Forecast, 2024 - 2031 (Market Value, In USD Mn)
      13.1 Vaccine type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.1.1 preventive vaccines
      2. 13.1.2 therapeutic vaccines
      13.2 Technology Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.2.1 DNA/viral‑vector vaccines
      2. 13.2.2 protein subunit vaccines
      3. 13.2.3 others
      13.3 End user Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.3.1 hospitals
      2. 13.3.2 research institutes
      3. 13.3.3 public health programs.​
      13.4 Country Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
      1. 13.4.1 Saudi Arabia
      2. 13.4.2 UAE
      3. 13.4.3 South Africa
      4. 13.4.4 Egypt
      5. 13.4.5 Israel
      6. 13.4.6 Rest of Middle East and Africa
    1. 13.5 Middle East & Africa Global HIV Vaccine Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report – Opportunity Analysis Index, Vaccine type, Technology, End user, and Country, 2024 - 2031
    2. 13.6 Regional Trends Analysis
    3. 13.7 Middle East & Africa Global HIV Vaccine Market & Competitive Intelligence, 2019 to 2023, Forecast 2024 to 2031 Research Report Research Report - Company Profiles
      1. 13.7.1 Company 1 (Saudi Arabia)
      2. 13.7.2 Company 2 (UAE)
      3. 13.7.3 Company 3 (UAE)
    14. Competition Landscape
    1. 14.1 Strategic Dashboard of Top Market Players
    2. 14.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)
      1. 14.2.1 Company 1
      2. 14.2.2 Company 2
      3. 14.2.3 Company 3
      4. 14.2.4 Company 4
      5. 14.2.5 Company 13
  1. 15. Data Collection Method and Research Approach
  1. 16. Principal Presumptions and Acronyms

Methodology & Credibility

Built for enterprise decisions, not vanity metrics.
Triangulated Sizing
Bottom-up, top-down, and peer benchmarks reconciled by analysts.
Primary + Secondary Research
Executive interviews combined with validated public and paid sources.
Scenario & Sensitivity
Base, bull and bear cases to stress-test strategic moves.
Need Confidence Fast?
We’ll map your questions to the report in 15 minutes.
Book A Consultation
Preferred by strategy, marketing, and corporate development teams.

Related Reports

More coverage in adjacent themes and segments.
Ready to move from data to decision?
Get the report, request a sample, or book a consultative briefing.
New chat message received
×

Need help?

Chat with our team in a minute.